The Apollo University Chittoor Ph.D Drug Delivery: Fees 2026, Course Duration, Dates, Eligibility

Ans. GPAT is not mandatory for admission to the Ph.D. (Drug Delivery) programme at TAU. Candidates who have qualified GPAT are exempted from the TAU-RET written entrance test, which is a significant advantage. However, candidates who have not qualified GPAT can still apply and must appear for the TAU-RET (The Apollo University Research Entrance Test), which consists of 50% research methodology and 50% subject-specific questions. Candidates scoring 50% or above in TAU-RET are shortlisted for the interview. So GPAT qualification streamlines the process but is not a prerequisite.

Ans. The Ph.D. (Drug Delivery) at AIPS, TAU, covers a broad spectrum of pharmaceutical research areas including novel drug delivery systems (nanoparticles, liposomes, microspheres, transdermal patches), drug design and development, pharmacological and toxicological studies, phytochemistry and herbal drug technology, biopharmaceutics, and formulation science. The specialisations are described as "not restricted," meaning scholars can propose interdisciplinary research topics in consultation with their assigned supervisor and the Research Advisory Committee, including areas like targeted drug delivery, controlled release systems, and nanomedicine.

Ans. The full-time Ph.D. has a minimum duration of 3 years and a maximum of 6 years, with an annual tuition fee of Rs. 20,000. The part-time Ph.D. has a minimum duration of 4 years and a maximum of 6 years, with an annual tuition fee of Rs. 50,000. For working professionals employed in the pharmaceutical industry, hospitals, or academic institutions, the part-time mode is more suitable as it allows them to continue their employment while pursuing research. Part-time candidates must submit a No Objection Certificate (NOC) from their employer. The coursework and thesis requirements are identical for both modes.

Ans. TAU mandates that all PhD scholars must publish a minimum of 2 research papers in Scopus or Web of Science (WoS) indexed journals from their PhD thesis work before they are eligible to submit the thesis. Additionally, scholars must present their work at a minimum of 2 conferences or seminars during their doctoral tenure. These requirements are in line with UGC 2022 regulations and ensure that the research conducted at TAU meets international quality standards. For drug delivery research, target journals typically include the International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Drug Delivery, and Journal of Controlled Release.

Ans. A Ph.D. in Drug Delivery opens diverse career pathways including Research Scientist or Senior Scientist roles in pharmaceutical companies (formulation R&D, drug delivery, and process development), academic positions (Assistant/Associate Professor in pharmacy colleges and universities), regulatory affairs specialist roles in companies dealing with novel drug delivery products, and positions in government research organisations such as CSIR, ICMR, and NIPER. The drug delivery sector is one of the most commercially active areas in pharma, with growing demand for specialists in nanoformulations, biologics delivery, and targeted therapy systems. Starting salaries in industry typically range from Rs. 5 to 12 LPA, with senior research roles commanding Rs. 15 to 30 LPA.

Ans. Yes. The eligibility criteria for the Ph.D. programme at TAU requires a Master's degree in a relevant discipline with a minimum of 55% marks. Candidates with M.Pharm in Pharmacology, Pharmaceutical Chemistry, Pharmacognosy, or related pharmaceutical sciences are eligible to apply for the Ph.D. (Drug Delivery), provided their research proposal aligns with the available supervisor expertise at AIPS. The Departmental Research Committee (DRC) evaluates the feasibility and relevance of the proposed research topic during the interview/viva-voce. Candidates from adjacent disciplines may be required to undertake additional coursework as recommended by the Research Advisory Committee.